Anders Valind
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Neurology top 10%
- Neuroblastoma Research and Treatments
Papers in ⓘ
-
- Cancer Genomics and Diagnostics 8
-
- Neuroblastoma Research and Treatments 6
- Co-authors
- David Gisselsson (21 shared papers)Jenny Karlsson (13 shared papers)Linda Holmquist Mengelbier (7 shared papers)Yuesheng Jin (2 shared papers)Caroline Jansson (7 shared papers)Bo Baldetorp (2 shared papers)Ingrid Øra (3 shared papers)Björn Bakker (1 shared paper)
- Journals
- Genes Chromosomes and Cancer (2 papers)Pediatric Blood & Cancer (2 papers)PLoS ONE (1 paper)Clinical Cancer Research (1 paper)Nature Genetics (1 paper)
- Partner nations
- SwedenNetherlandsJapan
In The Last Decade
Anders Valind
21 papers receiving 294 citations
Peers
Comparison fields: 5 of 41
- Cancer Research 121
- Neurology 97
- Oncology 92
- Molecular Biology 162
- Cell Biology 37
Countries citing papers authored by Anders Valind
This map shows the geographic impact of Anders Valind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Valind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Valind more than expected).
Fields of papers citing papers by Anders Valind
This network shows the impact of papers produced by Anders Valind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Valind. The network helps show where Anders Valind may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Valind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 46 | |
| 2 | 2022 | 43 | |
| 3 | 2015 | 35 | |
| 4 | 2020 | 28 | |
| 5 | 2014 | 25 | |
| 6 | 2013 | 23 | |
| 7 | 2013 | 19 | |
| 8 | 2016 | 14 | |
| 9 | 2023 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 9 | |
| 12 | 2022 | 5 | |
| 13 | 2014 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2018 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2016 | 2 |
About Anders Valind
Anders Valind is a scholar working on Cancer Research, Neurology, Oncology, Molecular Biology and Cell Biology, having authored 23 papers that have together received 296 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Renal and related cancers (7 papers), Neuroblastoma Research and Treatments (6 papers), Renal cell carcinoma treatment (3 papers), Microtubule and mitosis dynamics (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Genomics and Phylogenetic Studies (2 papers) and Prenatal Screening and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (121 citations), Neurology (97 citations), Oncology (92 citations), Molecular Biology (162 citations) and Cell Biology (37 citations). Anders Valind has collaborated with scholars based in Sweden, Netherlands and Japan. Frequent co-authors include David Gisselsson, Jenny Karlsson, Linda Holmquist Mengelbier, Yuesheng Jin, Caroline Jansson, Bo Baldetorp, Ingrid Øra, Björn Bakker, Catharina Hagerling and Ninib Baryawno. Their work appears in journals such as Genes Chromosomes and Cancer, Pediatric Blood & Cancer, PLoS ONE, Clinical Cancer Research and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.